Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · Real-Time Price · USD
5.33
-0.37 (-6.49%)
Mar 31, 2025, 1:43 PM EDT - Market open
Astria Therapeutics Market Cap
Astria Therapeutics has a market cap or net worth of $300.79 million as of March 31, 2025. Its market cap has decreased by -63.47% in one year.
Market Cap
300.79M
Enterprise Value
-1.10M
1-Year Change
-63.47%
Ranking
Category
Stock Price
$5.33
Market Cap Chart
Since June 25, 2015, Astria Therapeutics's market cap has increased from $180.00M to $300.79M, an increase of 67.11%. That is a compound annual growth rate of 5.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 321.70M | -36.23% |
| Dec 31, 2024 | 504.50M | 80.95% |
| Dec 29, 2023 | 278.80M | 11.30% |
| Dec 30, 2022 | 250.50M | 257.35% |
| Dec 31, 2021 | 70.10M | 63.02% |
| Dec 31, 2020 | 43.00M | -38.31% |
| Dec 31, 2019 | 69.70M | 124.84% |
| Dec 31, 2018 | 31.00M | -9.88% |
| Dec 29, 2017 | 34.40M | -48.89% |
| Dec 30, 2016 | 67.30M | -44.52% |
| Dec 31, 2015 | 121.30M | -32.61% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |